A phase Ib study of AZD1775 and olaparib combination in patients with refractory solid tumors. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not include a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results